(Q28248186)
Statements
Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer (English)
0 references
1 June 2005
0 references
23
0 references
16
0 references
3706-12
0 references